EUVIMEDEUVIMED entdecken
Crossref

Brain-wide microglia replacement using a nonconditioning strategy ameliorates pathology in mouse models of neurological disorders

Dadian Chen iD, Chen Wang iD, Xi Chen, Jiayu Li iD, Shuai Chen iD, Yanzhong Li, Fangling Ma, Tingting Li, Mengling Zou, Xin Li, Xiaohua Huang, Yun-Wu Zhang iD und 6 weitere

Science Translational Medicine · 30.04.2025 · 17 (796)

DOI: 10.1126/scitranslmed.ads6111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 30.04.2025. Verfasst von Dadian Chen und 17 weiteren Autor:innen. Beteiligte Einrichtung: Xiamen Key Laboratory of Brain Center, First Affiliated Hospital of Xiamen University and Fujian Provincial Key Laboratory of Neurodegenerative Disea…. Hauptthemen laut MEDLINE: Microglia, Brain, Nervous System Diseases. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 72 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Growing genetic and pathological evidence has identified microglial dysfunction as a key contributor to the pathogenesis and progression of various neurological disorders, positioning microglia replacement as a promising therapeutic strategy. Traditional bone marrow transplantation (BMT) methods for replenishing brain microglia have limitations, including low efficiency and the potential for brain injury because of preconditioning regimens, such as irradiation or chemotherapy. Moreover, BM-derived cells that migrate to the brain do not recapitulate the phenotypic and functional properties of resident microglia. Here, we present a microglia transplantation strategy devoid of any conditioning, termed “tricyclic microglial depletion for transplantation” (TCMDT). This approach leverages three cycles of microglial depletion using the colony stimulating factor 1 receptor (CSF1R) inhibitor PLX3397, creating an optimal window for efficient engraftment of exogenous microglia. Transplantation of primary cultured microglia by TCMDT successfully restored the identity and functions of endogenous microglia. To evaluate the therapeutic potential of TCMDT, we applied this strategy to two distinct mouse models of neurologic disorder. In a Sandhoff disease model, a neurodegenerative lysosomal storage disorder caused by hexosaminidase subunit beta ( Hexb ) deficiency, TCMDT effectively replaced deficient microglia, attenuating neurodegeneration and improving motor performance. Similarly, in an Alzheimer’s disease (AD)–related amyloid mouse model carrying the triggering receptor expressed on myeloid cells 2 (Trem2) R47H mutation, our transplantation strategy rescued microglial dysfunction and mitigated AD-related pathology. Overall, our study introduces TCMDT as a practical, efficient, and safe approach for microglia replacement, suggesting therapeutic potential for treating neurological disorders associated with microglial dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaBrainNervous System DiseasesAnimalsDisease Models, AnimalMiceMice, Inbred C57BLReceptors, Granulocyte-Macrophage Colony-Stimulating FactorAminopyridinesPyrroles

Substanzen

Receptors, Granulocyte-Macrophage Colony-Stimulating FactorpexidartinibAminopyridinesPyrroles

Autor:innen und Institutionen

  • Xiamen Key Laboratory of Brain Center, First Affiliated Hospital of Xiamen University and Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, School of Medicine,…
  • Department of Neurology and Department of Neuroscience, Xiamen Medical Quality Control Center for Neurology, First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian 361005,…
  • Department of Neurosurgery, First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian 361005, China.
  • Department of Otolaryngology-Head and Neck Surgery, First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian 361005, China.
  • Basic Medical Sciences, School of Medicine, Xiamen University, Xiamen, Fujian 361102, China.
  • Division of Life Science and State Key Laboratory of Molecular Neuroscience, Hong Kong University of Science and Technology, Hong Kong, China.

ORCID-Profile: Dadian Chen, Chen Wang, Jiayu Li, Shuai Chen, Yun-Wu Zhang, Yingjun Zhao, Guojun Bu, Honghua Zheng, Xiao-Fen Chen, Jie Zhang, Li Zhong

Zitieren

APA

Chen, D., Wang, C., Chen, X., Li, J., Chen, S., Li, Y., Ma, F., Li, T., Zou, M., Li, X., Huang, X., Zhang, Y. W., Zhao, Y., Bu, G., Zheng, H., Chen, X. F., Zhang, J., & Zhong, L. (2025). Brain-wide microglia replacement using a nonconditioning strategy ameliorates pathology in mouse models of neurological disorders. Science Translational Medicine, 17(796). https://doi.org/10.1126/scitranslmed.ads6111

Vancouver

Chen D, Wang C, Chen X, Li J, Chen S, Li Y, et al. Brain-wide microglia replacement using a nonconditioning strategy ameliorates pathology in mouse models of neurological disorders. Science Translational Medicine. 2025;17(796). doi:10.1126/scitranslmed.ads6111

BibTeX
@article{Chen2025,
  author = {Chen, Dadian and Wang, Chen and Chen, Xi and Li, Jiayu and Chen, Shuai and Li, Yanzhong and Ma, Fangling and Li, Tingting and Zou, Mengling and Li, Xin and Huang, Xiaohua and Zhang, Yun-Wu and Zhao, Yingjun and Bu, Guojun and Zheng, Honghua and Chen, Xiao-Fen and Zhang, Jie and Zhong, Li},
  title = {Brain-wide microglia replacement using a nonconditioning strategy ameliorates pathology in mouse models of neurological disorders},
  journal = {Science Translational Medicine},
  year = {2025},
  volume = {17},
  number = {796},
  doi = {10.1126/scitranslmed.ads6111}
}
Kostenlos starten →